Localização do estoque

New Jersey, USA
Czech Republic, EU
Mumbai, India

* Estoque sujeito a disponibilidade

Documentation

Baixar MSDS

Baixar COA de amostra

Inclui: HPLC, MASS/LC-MS, RMN de 1H, FT-IR, teor, Relatório de Elucidação Estrutural (SER) e dados analíticos adicionais dependendo do produto.

Axitinib Nitroso Impurity 4

● Em Estoque

Nº do catálogo:	VE0024259
Nº CAS:	N/A
Fórmula Mol.::	C15H11IN4O2S
Peso Mol.::	438.24 g/mol

Solicitar orçamento

Adicionar à lista de RFQ

Informações adicionais sobre o Axitinib Nitroso Impurity 4

Fármaco de origem

N/A

Nome IUPAC

2-((3-iodo-1-nitroso-1H-indazol-6-yl)thio)-N-methylbenzamide

Sinônimos farmacopeicos

N/A

Outros sinônimos

N/A

SMILES

IC1=NN(N=O)C2=CC(SC3=CC=CC=C3C(NC)=O)=CC=C21

InChI

InChI=1S/C15H11IN4O2S/c1-17-15(21)11-4-2-3-5-13(11)23-9-6-7-10-12(8-9)20(19-22)18-14(10)16/h2-8H, 1H3, (H, 17, 21)

Descrição

Axitinib Nitroso Impurity 4 is an N-nitroso derivative of the secondary amine present | which is a highly characterized reference material that meets stringent regulatory standards set for nitrosamine compounds | including those set by USP | EMA | JP | and BP. This nitroso standard is essential for a variety of applications | such as analytical method development | method validation (AMV) | and Quality Control (QC). It is suitable for use in both Abbreviated New Drug Applications (ANDA) and New Drug Applications (NDA). This nitrosamine standard helps establish detection limits | quantify impurity levels | and ensure trace nitroso impurities in pharmaceutical products remain within FDA and EMA safety limits.